James Stanker | Chief Financial Officer |
David Young | Chief Executive Officer |
François Brisebois | Oppenheimer & Co. Inc. |
Aydin Huseynov | The Benchmark Company, LLC |
Robin Garner | Craig-Hallum Capital Group LLC |
Greetings and welcome to Processa Pharmaceuticals Second Quarter 2021 Earnings Conference Call and Corporate Update. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions].
As a reminder, this conference call is being recorded.